People are presumably taking profits after buying in the low 40s, while shorters are presumably trying to limit their losses. Move along, nothing to see here. IMO
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling